AdaptHealth (AHCO) Stock Price, News & Analysis

Company Overview

AdaptHealth, Inc. operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions. In addition to respiratory therapy, AdaptHealth offers mobility aids like power wheelchairs, walkers and patient lifts, as well as bathroom safety equipment including walk-in tubs, shower chairs and grab bars. These products are supported by in-home setup, training and ongoing clinical monitoring services.

AdaptHealth maintains a nationwide network of patient care centers, serving all 50 states and Puerto Rico through both direct shipments and in-home visits. In October 2022, the company completed the acquisition of Apria Healthcare, further expanding its distribution footprint and service capabilities. AdaptHealth leverages proprietary data analytics and telehealth platforms to track patient adherence and provide remote clinical follow-up.

Founded in 2007 and headquartered in Woburn, Massachusetts, AdaptHealth went public on the Nasdaq under the ticker AHCO in 2014. The company is led by a management team with deep expertise in healthcare operations, regulatory compliance and patient care. AdaptHealth continues to pursue strategic partnerships and acquisitions to broaden its product offerings and strengthen its position in the home healthcare market.

Key Stats

• Today's Range: $9.27 to $9.50
• 50-Day Range: $8.75 to $10.11
• 52-Week Range: $7.11 to $11.70
• Volume: 796,826 shs
• Average Volume: 852,261 shs
• Market Capitalization: $1.26 billion
• P/E Ratio: 17.20
• Dividend Yield: N/A
• Price Target: $13.40
• Consensus Rating: Buy

AdaptHealth Stock Analysis - MarketRank™

AdaptHealth scored higher than 74% of companies evaluated by MarketBeat, and ranked 286th out of 953 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

AdaptHealth has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.

Upside Potential

AdaptHealth has a consensus price target of $13.40, representing about 44.2% upside from its current price of $9.29.

Amount of Analyst Coverage

AdaptHealth has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 10.23%

Earnings Growth

Earnings for AdaptHealth are expected to grow by 10.23% in the coming year, from $0.88 to $0.97 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of AdaptHealth is 17.20, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 280.89.

Price to Earnings Ratio vs. Sector

The P/E ratio of AdaptHealth is 17.20, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 75.41.

Price to Earnings Growth Ratio

AdaptHealth has a PEG Ratio of 1.07. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

AdaptHealth has a P/B Ratio of 0.79. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

11.55% of the float of AdaptHealth has been sold short.

Short Interest Ratio / Days to Cover

AdaptHealth has a short interest ratio ("days to cover") of 8.4.

Change versus previous month

Short interest in AdaptHealth has recently increased by 4.50%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

AdaptHealth does not currently pay a dividend.

Dividend Growth

AdaptHealth does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

11.55% of the float of AdaptHealth has been sold short.

Short Interest Ratio / Days to Cover

AdaptHealth has a short interest ratio ("days to cover") of 8.4.

Change versus previous month

Short interest in AdaptHealth has recently increased by 4.50%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 3.5 / 5
• News Sentiment: 1.27

News Sentiment

AdaptHealth has a news sentiment score of 1.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.93 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for AdaptHealth this week, compared to 4 articles on an average week.

Search Interest

4 people have searched for AHCO on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, AdaptHealth insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $79,786.00 in company stock.

Percentage Held by Insiders

Only 1.55% of the stock of AdaptHealth is held by insiders.

Percentage Held by Institutions

82.67% of the stock of AdaptHealth is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

AHCO Stock Analysis - Frequently Asked Questions

How have AHCO shares performed this year?

AdaptHealth's stock was trading at $9.52 on January 1st, 2025. Since then, AHCO shares have decreased by 2.4% and is now trading at $9.29.

How were AdaptHealth's earnings last quarter?

AdaptHealth Corp. (NASDAQ:AHCO) released its earnings results on Tuesday, November, 5th. The company reported $0.15 EPS for the quarter, missing analysts' consensus estimates of $0.17 by $0.02. The firm's revenue was up .2% compared to the same quarter last year.
Read the conference call transcript.

Who are AdaptHealth's major shareholders?

AdaptHealth's top institutional investors include Reinhart Partners LLC. (5.42%), Segall Bryant & Hamill LLC (3.47%), Jefferies Financial Group Inc. and Palisade Capital Management LP (1.95%). Insiders that own company stock include Everest Hill Group Inc, Skyknight Aero Holdings, Llc, Shaw Rietkerk, Jason A Clemens, Daniel Bunting, Albert A Prast and David Solomon Williams III.
View institutional ownership trends.

How do I buy shares of AdaptHealth?

Shares of AHCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of AdaptHealth own?

Based on aggregate information from My MarketBeat watchlists, some other companies that AdaptHealth investors own include Waste Connections (WCN), AU Optronics (AUOTY), American Water Works (AWK), DiamondRock Hospitality (DRH), The RMR Group (RMR), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

• Last Earnings: 11/05/2024
• Today: 9/14/2025
• Next Earnings (Estimated): 11/04/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:AHCO
• CIK: 1725255
• Web: www.adapthealth.com
• Phone: (610) 424-4515
• Fax: N/A
• Employees: 10,500
• Year Founded: N/A

Price Target and Rating

• Average Price Target for AdaptHealth: $13.40
• High Price Target: $16.00
• Low Price Target: $11.00
• Potential Upside/Downside: +44.2%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.54
• Trailing P/E Ratio: 17.20
• Forward P/E Ratio: 10.56
• P/E Growth: 1.07
• Net Income: $90.42 million
• Net Margins: 2.49%
• Pretax Margin: 4.60%
• Return on Equity: 5.01%
• Return on Assets: 1.77%

Debt

• Debt-to-Equity Ratio: 1.14
• Current Ratio: 1.06
• Quick Ratio: 0.82

Sales & Book Value

• Annual Sales: $3.24 billion
• Price / Sales: 0.39
• Cash Flow: $3.70 per share
• Price / Cash Flow: 2.51
• Book Value: $11.72 per share
• Price / Book: 0.79

Miscellaneous

• Outstanding Shares: 135,298,000
• Free Float: 133,201,000
• Market Cap: $1.26 billion
• Optionable: Optionable
• Beta: 1.59